Otolaryngologic Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 25, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.5698?guestAccessKey=c6568d70-d400-4a48-b969-17bd8835303b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022521

 

What The Study Did: This research letter describes the various otolaryngologic manifestations in patients 18 years or younger with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.

Authors: Ryan C. T. Cheong, B.Sc.(Hons), M.B.B.S., of the Great Ormond Street Hospital for Children NHS Trust in London, United Kingdom, is the corresponding author.

 

(doi:10.1001/jamaoto.2020.5698)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.